Targeting an Fgfr3 Enhancer as a Potential Therapeutic Tool for Achondroplasia

被引：0
|
作者：
Angelozzi, Marco [1 ]
Molin, Arnaud [1 ]
Karvande, Anirudha [1 ]
Fernandez-Iglesias, Angela [1 ]
Haseeb, Abdul [1 ]
Whipple, Samantha [1 ]
Lefebvre, Veronique [1 ]
机构：
[1] Childrens Hosp Philadelphia, Philadelphia, PA USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI-159
引用
收藏
页码：28 / 29
页数：2
相关论文
共 50 条
  • [31] ACHONDROPLASIA IS DEFINED BY RECURRENT G380R MUTATIONS OF FGFR3
    BELLUS, GA
    HEFFERON, TW
    DELUNA, RIO
    HECHT, JT
    HORTON, WA
    MACHADO, M
    KAITILA, I
    MCINTOSH, I
    FRANCOMANO, CA
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 56 (02) : 368 - 373
  • [32] FGFR3 gene mutations in transmembrane domain in Chinese achondroplasia and hypochondroplasia patients
    Gao, YL
    Ni, JH
    Lu, GQ
    Wang, W
    Wang, DF
    HORMONE RESEARCH, 1998, 49 : 57 - 57
  • [33] Severe complications in a child with achondroplasia and two FGFR3 mutations on the same allele
    Rump, P
    Letteboer, TGW
    Gille, JJP
    Torringa, MJL
    Baerts, W
    van Gestel, JPJ
    Verheij, JBGM
    van Essen, AJ
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2006, 140A (03) : 284 - 290
  • [34] Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer
    Andrew J. Weickhardt
    David K. Lau
    Margeaux Hodgson-Garms
    Austen Lavis
    Laura J. Jenkins
    Natalia Vukelic
    Paul Ioannidis
    Ian Y. Luk
    John M. Mariadason
    BMC Cancer, 22
  • [35] Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer
    Weickhardt, Andrew J.
    Lau, David K.
    Hodgson-Garms, Margeaux
    Lavis, Austen
    Jenkins, Laura J.
    Vukelic, Natalia
    Ioannidis, Paul
    Luk, Ian Y.
    Mariadason, John M.
    BMC CANCER, 2022, 22 (01)
  • [36] Targeting the ectodomain of FGFR3 in multiple meloma.
    Green, D
    Olsen, S
    Pinnell, J
    Mohammadi, M
    BLOOD, 2003, 102 (11) : 681A - 681A
  • [37] Effect of FGFR3 Juxtamembrane Domain on FGFR3 Dimerization
    Sarabipour, Sarvenaz
    Li, Edwin
    Hristova, Kalina
    BIOPHYSICAL JOURNAL, 2011, 100 (03) : 546 - 546
  • [38] Soluble FGFR-3 as potential therapy for achondroplasia
    Nature Reviews Endocrinology, 2013, 9 (12) : 692 - 692
  • [39] Spectrum of genomic alterations in FGFR3: current appraisal of the potential role of FGFR3 in advanced urothelial carcinoma
    Sethakorn, Nan
    O'Donnell, Peter H.
    BJU INTERNATIONAL, 2016, 118 (05) : 680 - 690
  • [40] A Novel Mutation p.Ser348Cys in FGFR3 Causes Achondroplasia
    Hasegawa, Kosei
    Fukuhara, Rie
    Moriwake, Tadashi
    Tanaka, Hiroyuki
    Higuchi, Yousuke
    Yamashita, Miho
    Tsukahara, Hirokazu
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2016, 170 (05) : 1370 - 1372
12345